Robert L. Hunter
49Patents
25h-index
14Co-inventors
82Inventor score
Filing activity: Mar 17, 1977 → Mar 22, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5554372A | Methods and vaccines comprising surface-active copolymers | Human Necessities | 105 | Expired |
| US5089260A | Method of treating ischemic tissue | Human Necessities | 92 | Expired |
| US4485457A | Memory system including RAM and page switchable ROM | Human Necessities | 85 | Expired |
| US5696298A | Polyoxypropylene/polyoxyethylene copolymers with improved biological activity | Chemistry; Metallurgy | 60 | Expired |
| US5030448A | Method of delivering drugs to damaged or diseased tissue | Human Necessities | 51 | Expired |
| US4879109A | Method for treating burns | Emerging Cross-Sectional Technologies | 51 | Expired |
| US5071649A | Method of preventing blockage in catheters | Human Necessities | 47 | Expired |
| US5039520A | Plasma extender | Human Necessities | 41 | Expired |
| US5523492A | Polyoxypropylene/polyoxyethylene copolymers with improved biological activity | Chemistry; Metallurgy | 39 | Expired |
| US5041288A | Method of treating tissue damaged by reperfusion injury | Human Necessities | 38 | Expired |
| US5622649A | Multiple emulsions and methods of preparation | Performing Operations; Transporting | 38 | Expired |
| US5885590A | Oral vaccines comprising multiple emulsions and methods of preparation | Performing Operations; Transporting | 37 | Expired |
| US5017370A | Improved method of performing angioplasty procedures | Human Necessities | 35 | Expired |
| US5028599A | Method of treating mycardial damage | Human Necessities | 32 | Expired |
| US5047236A | Method of treating stroke | Human Necessities | 31 | Expired |
| US4801452A | Fibrinolytic composition | Human Necessities | 31 | Expired |
| US5080894A | Method and composition for reducing tissue damage | Human Necessities | 29 | Expired |
| US4897263A | Methods and compositions for treatment of pathological hydrophobic interactions in biological fluids | Human Necessities | 29 | Expired |
| US5078995A | Fibrionolytic composition | Human Necessities | 28 | Expired |
| US4937070A | Methods and compositions for treatment of pathological hydrophobic interactions in biological fluids | Human Necessities | 28 | Expired |
| US4837014A | An improved method of treating sickle cell anemia | Human Necessities | 26 | Expired |
| US5032394A | Method of treating burns | Emerging Cross-Sectional Technologies | 26 | Expired |
| US5064643A | Method for treating sickle cell disease | Human Necessities | 26 | Expired |
| US4997644A | Method of treating adult respiratory distress syndrome | Human Necessities | 25 | Expired |
| US4873083A | Fibrinolytic composition | Human Necessities | 25 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.